Models, biopsychosocial
Conditions
Interventions
A group of 100 individuals with shoulder pain, of both sexes and aged between 18 and 60 years, will be recruited. They will have to present pain in anterior, posterior ou lateral region of the shoulde
Sponsors
Fundação de Amparo à Pesquisa do Estado de São Paulo
Universidade Federal de São Carlos
Eligibility
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Individuals from both sexes, aged from 18 to 60 years old who report rotator cuff-related shoulder pain in the anterior, lateral or posterior region during arm movement, for more than 4 weeks and intensity of at least 3/10 on the Numerical Pain Rating Scale (NPRS) will be recruited.
Exclusion criteria
Exclusion criteria: Individuals with shoulder pain associated with any of the following conditions will not included: history of recurring shoulder dislocation, adhesive capsulitis (loss of 50% of passive range of motion in any direction), surgery or recent fracture (less than one year) in the upper quarter of the body, inflammatory diseases (rheumatics, infections, or related to neural, vascular or neurological causes), neurological or psychiatric diseases, history of cancer, pregnancy, cognitive deficit, physical therapy treatment or corticoid injection in the previous 6 months or any diagnose of central sensitization syndrome. Exclusion criteria will be non-attendance at the full evaluation process and incapacity to understand the questionnaires or complete all the tests.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected Outcome 1: The WHO Disability Assessment Schedule (WHODAS) will be used to assess the individual's general functioning. Greater general disability is expected to be found in individuals with a nociplastic pain phenotype when compared to individuals with nociceptive or neuropathic pain. ;Expected Outcome 2: The Brazilian version of the Shoulder Pain and Disability Index (SPADI) will be used to assess shoulder function. Greater shoulder disability is expected to be found in individuals with a nociplastic pain phenotype, compared to those with nociceptive or neuropathic pain. | — |
Secondary
| Measure | Time frame |
|---|---|
| Psychosocial aspects will be: Tampa Scale of Kinesiophobia (TSK) to assess fear of movement, Pain Catastrophizing Scale (PCS) to assess pain catastrophizing, Pain Self-Efficacy Questionnaire (PSEQ) to assess self-efficacy, Hospital Anxiety and Depression Scale (HADS) adapted to Portuguese to assess symptoms of anxiety and depression, and Pittsburgh Sleep Quality Index (PSQI) to assess sleep quality.;Expected outcome 3: shoulder range of motion is expected to be reduced in people with nociceptive and neuropatic pain, when compared to those with nociplastic pain.;Expected outcome 4: Shoulder pain intensity is expected to be increased in peoplw with neuropathic and nociplastic pain, compared to those with nociceptive pain.;Expected outcome 5: Quantitative sensory testing. It's expected to see lower pain thresholds in those classified as predominant nociplastic shoulder pain when compared to those with nociceptive or neuropathic shoulder pain.;Expected outcome 6: Tampa Scale of Kinesiophobia (TSK) to assess fear of movement. This outcome is expected to be increased in those with nociplastic pain, compared to the other two pain phenotypes.;Expected outcome 7: Pain Catastrophizing Scale (PCS) to assess pain catastrophizing. This outcomes is expected to be increased in those with nociplastic pain, compared to the other two pain phenotypes. ;Expected outcome 9: Hospital Anxiety and Depression Scale (HADS) to assess symptoms of anxiety and depression. This outcome is expected to be increased in those with nociplastic pain, compared to the other two pain phenotypes. ;Expected outcome 10: Pittsburgh Sleep Quality Index (PSQI) to assess sleep quality. This outcome is expected to be reduced in those with nociplastic pain, compared to the other two pain phenotypes. | — |
Countries
BR
Contacts
Public ContactMelina Guilherme
Universidade Federal de São Carlos
Outcome results
None listed